<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101650643</journal-id>
<journal-id journal-id-type="pubmed-jr-id">43527</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Stem Cell Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr Stem Cell Rep</journal-id>
<journal-title-group>
<journal-title>Current stem cell reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2198-7866</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28983454</article-id>
<article-id pub-id-type="pmc">5624725</article-id>
<article-id pub-id-type="doi">10.1007/s40778-017-0080-x</article-id>
<article-id pub-id-type="manuscript">NIHMS859847</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Organoid and Organ-On-A-Chip Systems: New Paradigms for Modeling Neurological and Gastrointestinal Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Akhtar</surname>
<given-names>Aslam Abbasi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sances</surname>
<given-names>Samuel</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barrett</surname>
<given-names>Robert</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Breunig</surname>
<given-names>Joshua J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="author-notes" rid="FN1">†</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048</aff>
<aff id="A2">
<label>2</label>Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048</aff>
<aff id="A3">
<label>3</label>F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048</aff>
<aff id="A4">
<label>4</label>Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048</aff>
<aff id="A5">
<label>5</label>Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, 90095, USA</aff>
<author-notes>
<corresp id="FN1"><label>†</label>Address correspondence to: Dr. Joshua Breunig, Regenerative Medicine Institute, AHSP A8109, Los Angeles, CA 90048. Phone: 310-423-1159. <email>joshua.breunig@cshs.org</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p><bold>Conflict of Interest:</bold> Aslam Abbasi Akhtar and Joshua J. Breunig declare that they have no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>5</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2018</year>
</pub-date>
<volume>3</volume>
<issue>2</issue>
<fpage>98</fpage>
<lpage>111</lpage>
<!--elocation-id from pubmed: 10.1007/s40778-017-0080-x-->
<self-uri xlink:href="https://link.springer.com/article/10.1007%2Fs40778-017-0080-x"></self-uri>
<abstract>
<sec id="S1">
<title>Purpose of review</title>
<p id="P1">The modeling of biological processes <italic>in vitro</italic> provides an important tool to better understand mechanisms of development and disease, allowing for the rapid testing of therapeutics. However, a critical constraint in traditional monolayer culture systems is the absence of the multicellularity, spatial organization, and overall microenvironment present <italic>in vivo</italic>. This limitation has resulted in numerous therapeutics showing efficacy <italic>in vitro</italic>, but failing in patient trials. In this review, we discuss several organoid and “organ-on-a-chip” systems with particular regard to the modeling of neurological diseases and gastrointestinal disorders.</p>
</sec>
<sec id="S2">
<title>Recent findings</title>
<p id="P2">Recently, the <italic>in vitro</italic> generation of multicellular organ-like structures, coined organoids, has allowed the modeling of human development, tissue architecture, and disease with human-specific pathophysiology. Additionally, microfluidic “organ-on-a-chip” technologies add another level of physiological mimicry by allowing biological mediums to be shuttled through 3D cultures.</p>
</sec>
<sec id="S3">
<title>Summary</title>
<p id="P3">Organoids and organ-chips are rapidly evolving <italic>in vitro</italic> platforms which hold great promise for the modeling of development and disease.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Organoid</kwd>
<kwd>microfluidics</kwd>
<kwd>organ-on-a-chip</kwd>
<kwd>BBB-chip</kwd>
<kwd>personalized medicine</kwd>
<kwd>disease modeling</kwd>
<kwd>gut organoids</kwd>
<kwd>cerebral organoids</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>